Expression of Interest (EOI) for B-L.I.F.E. Manufacturing, Marketing, Distribution and Support
The B-L.I.F.E. system is a CSIR developed BiPAP device, specifically intended to assist patients experiencing respiratory distress due to Covid-19 infection. As a simple ventilation enhancement system, it is designed to meet the demand for early-stage patients experiencing respiratory difficulty and requiring low-level assistance of oxygen-enhanced respiratory air.
The B-L.I.F.E. system is ready to be manufactured and marketed in South Africa and beyond, with the aim of creating and expanding manufacturing activity and associated job creation. The current EoI call is targeted at new or existing SMMEs performing the discrete manufacturing in this sector to grow and expand manufacturing capacity to meet market demands.
Click here to submit the EoI.
The CSIR BiPAP Lung Inspiratory Flow Enabler, (B-L.I.F.E.) is a non-invasive ventilation system (NVS) which supplies an adjustable pressurized mixture of air and oxygen to the patient through a mask or hood. The pressurized gas helps the patient by supplying a higher percentage level of oxygenated air and by keeping the airway and lung pressure elevated above ambient air pressure, specifically during the exhale portion of the breathing cycle to keep the lung alveoli recruited and improve operating efficacy. The medical operator can adjust the fraction inspired oxygen (FiO2) of the air supplied to the patient and can adjust the elevated pressure to the required level. Filters are used in the air circuit to ensure the system remains hygienic and with new filters and relevant accessories can be used sequentially with multiple patients. In BiPAP mode the system maintains higher pressures during inhalation and lower pressures during exhalation.
The BiPAP system consists of an electronic control board, enclosure, and specialized plastic components which might require 3D printing or injection moulding. The device has a high percentage of local content, and this must be retained during the manufacturing of the device.
The current EoI call is targeted at new or existing SMMEs performing the discrete manufacturing in this sector to grow and expand manufacturing capacity to meet market demands.
- Company Track Record
- Transformation and BBEEE
- Business Readiness
Current Regulatory Status and Compliance
Established and localised supply chain
Distribution to Markets: Internation and Local Footprint
Product Support Capability
See EoI document for more details on the selection criteria